Ying has been made a fellow of the Institute of Electrical and Electronics Engineers for her contributions to fast magnetic resonance imaging with sparse sampling.
EIN Presswire reported that POP Biotechnologies, co-founded by Jonathan Lovell, will collaborate with UB to pursue the development of a unique vaccine approach against seasonal influenza.
Alevriadou is recognized for her pioneering cellular and molecular work on vascular endothelial mechanotransduction and mitochondrial redox signaling, and for her service to the society.
WKBW-TV quoted Jonathan Lovell in an article about his work developing a vaccine for Alzheimer’s disease. The treatment was effective in mice and the team is moving to gain FDA approval for human testing.
